Finance

Beta
Lists
ECL:NYSE
Ecolab Inc
$257.97
+1.43%
(+3.64) 1D
$257.97
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ECL...
Open
$256.78
High
$261.29
Low
$256.35
Mkt. cap
72.60B
Avg. vol.
1.64M
Volume
2.35M
Dividend
1.13%
Quarterly dividend
$0.73
Ex-dividend date
Jun 16, 2026
P/E ratio
34.91
52-wk high
$309.27
52-wk low
$243.15
EPS
$7.39
Beta
0.90
Shares outstanding
281.44M
No. of employees
48K
Open
$256.78
High
$261.29
Low
$256.35
Mkt. cap
72.60B
Avg. vol.
1.64M
Volume
2.35M
Dividend
1.13%
Quarterly dividend
$0.73
Ex-dividend date
Jun 16, 2026
P/E ratio
34.91
52-wk high
$309.27
52-wk low
$243.15
EPS
$7.39
Beta
0.90
Shares outstanding
281.44M
No. of employees
48K
Analyst outlook
Analyst Ratings
Based on 19 analysts giving stock ratings to ECL in the past 3 months
Strong Buy
Buy
16
Hold
3
Sell
0
12 month forecast
Based on 19 Wall Street analysts offering 12 month price targets for ECL in the last 3 months.
Highest
Current $257.97
$345.00 (+33.74%)
Average
$318.47 (+23.45%)
Lowest
$260.00 (+0.79%)
News stories
From sources across the web
Profile
Ecolab Inc., headquartered in Saint Paul, Minnesota, provides products related to water treatment, sanitation, and hygiene, primarily to commercial and industrial customers. The company is ranked 274th on the Fortune 500 and 569th on the Forbes Global 2000. Wikipedia
About Ecolab Inc
CEOChristophe Beck
Employees48K
Founded1923
HeadquartersSaint Paul, Minnesota, United States
SectorSpeciality chemicals
Websiteecolab.com
Last report
Apr 28, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$1.70 / $1.70
+0.16%beat
Revenue / Est. (USD)
4.07B / 4.01B
+1.28%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.03B
4.16B
4.20B
4.07B
Cost of goods sold
2.22B
2.30B
2.35B
2.28B
Cost of revenue
2.22B
2.30B
2.35B
2.28B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.05B
1.07B
1.05B
1.09B
Operating expense
1.05B
1.07B
1.05B
1.09B
Total operating expenses
3.28B
3.37B
3.40B
3.38B
Operating income
750.20M
799.50M
799.30M
688.50M
Other non operating income
-
-
-
-
EBT including unusual items
659.90M
717.70M
660.30M
558.10M
EBT excluding unusual items
687.00M
744.20M
735.00M
615.80M
Income tax expense
131.40M
128.00M
91.70M
121.50M
Effective tax rate
19.91%
17.83%
13.89%
21.77%
Other operating expenses
-
-
-
-
Net income
524.20M
585.00M
563.90M
432.60M
Net profit margin
13.02%
14.05%
13.44%
10.64%
Earnings per share
1.89
2.07
2.08
1.70
Interest and investment income
13.00M
19.30M
18.60M
4.60M
Interest expense
-76.20M
-74.60M
-82.90M
-77.30M
Net interest expenses
-63.20M
-55.30M
-64.30M
-72.70M
Depreciation and amortization charges
-
-
-
-
EBITDA
991.90M
1.04B
1.06B
951.60M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer